Amlodipine duration of action
Pro Research Analysisby 
Searched over 200M research papers
Duration of Action of Amlodipine
Introduction to Amlodipine's Pharmacokinetics
Amlodipine, a third-generation dihydropyridine calcium antagonist, is known for its long plasma half-life and sustained pharmacological effects. This unique profile allows for once-daily dosing, making it a convenient option for patients with hypertension and angina2 8.
Long Plasma Half-Life and Steady-State Blood Levels
Amlodipine's long plasma half-life, ranging from 35 to 50 hours, ensures that steady-state blood levels are achieved with a once-daily dose regimen. This characteristic is crucial for maintaining consistent blood pressure control over a 24-hour period2 7. Studies have shown that amlodipine significantly reduces both daytime and nighttime blood pressure, demonstrating its effective 24-hour duration of action2.
Sustained Antihypertensive Effect
The antihypertensive effect of amlodipine is sustained throughout the dosing period, with minimal trough-to-peak variability. This is supported by pharmacokinetic-pharmacodynamic modeling, which shows a strong correlation between amlodipine plasma concentrations and blood pressure reductions3. Additionally, amlodipine maintains its antihypertensive effect even when doses are missed for up to three days, indicating a prolonged duration of action beyond the 24-hour dosing interval7.
Comparative Studies with Other Calcium Antagonists
Comparative studies have highlighted amlodipine's superior duration of action and lower pharmacokinetic variability compared to other calcium antagonists like nifedipine. Amlodipine provides a more sustained effect with less intra- and inter-subject variability, maintaining its pharmacological activity up to 48 hours post-dose1. This makes it a reliable option for once-daily treatment in managing hypertension.
Clinical Implications and Benefits
The long duration of action of amlodipine translates into several clinical benefits. It ensures consistent blood pressure control, reduces the risk of cardiovascular events, and improves patient adherence to medication regimens due to its once-daily dosing schedule. Moreover, the slow onset of action minimizes the incidence of reflex tachycardia and vasodilator side effects, making it a well-tolerated option for long-term use8 10.
Conclusion
Amlodipine's long plasma half-life and sustained antihypertensive effect make it an effective and convenient option for managing hypertension and angina. Its ability to maintain blood pressure control over a 24-hour period, even with missed doses, underscores its reliability and patient-friendly profile. These attributes, combined with its minimal side effects, position amlodipine as a preferred choice among calcium antagonists for long-term cardiovascular management.
Sources and full results
Most relevant research papers on this topic
A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects.
Amlodipine provides a more sustained effect and less variability than nifedipine GITS, with pharmacological activity up to 48 hours post-dose.
Non-RCT24 h blood pressure control with the once daily calcium antagonist, amlodipine.
Amlodipine effectively reduces blood pressure in hypertensive patients over a 24-hour period, with a once-daily dose regimen providing steady state blood levels.
RCTPharmacodynamic modeling of the antihypertensive response to amlodipine
Amlodipine effectively reduces blood pressure in individuals with essential hypertension, providing a sustained antihypertensive response over 24 hours with minimal trough-to-peak variability.
Non-RCTAmlodipine in chronic stable angina: results of a multicenter double-blind crossover trial.
Amlodipine effectively increases exercise duration and reduces angina attacks, while maintaining symptom control in chronic stable angina patients.
RCTA comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine.
Both telmisartan and amlodipine effectively reduce blood pressure in patients with mild-to-moderate hypertension, but ambulatory blood pressure monitoring shows differences in their effectiveness.
RCT
Highly CitedPharmacologic profile of amlodipine.
Amlodipine is a potent calcium antagonist and effective oral antihypertensive agent with natriuretic properties, making it a potential first-line treatment for hypertension.
Non-RCT
Animal StudyHighly CitedProlonged antihypertensive effect of amlodipine: a prospective double-blind randomized study.
Amlodipine's antihypertensive effect extends beyond 24 hours, and when patients omit their treatment for 3 days, blood pressure does not significantly increase.
RCT